Atomwise is a technology-enabled pharmaceutical company that utilizes artificial intelligence to transform small molecule drug discovery. By applying deep learning to structure-based drug design, Atomwise's advanced AI discovery engine excels in identifying and optimizing novel therapeutic compounds across a broad array of protein types, including challenging targets. The company aims to develop a proprietary pipeline of small-molecule drug candidates with the goal of inventing better medicines more efficiently. Atomwise emphasizes diversity and inclusion in its workforce, believing that a varied team is essential for creating innovative solutions that meet the needs of diverse populations.